Literature DB >> 107464

Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.

J P Neijt, A C van Lindert, C P Vendrik, K J Roozendaal, A Struyvenberg, H M Pinedo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107464

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


× No keyword cloud information.
  4 in total

Review 1.  Chemotherapy in advanced ovarian cancer.

Authors:  C J Rodenburg; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-05       Impact factor: 1.798

3.  Prospective study with HEXA-CAF combination in ovarian carcinoma.

Authors:  G De Palo; R Demicheli; P Valagussa; M De Lena; E Villa
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 4.  Hexamethylmelamine and hexamethylmelamine hydrochloride.

Authors:  H P van de Vaart-van Zutphen; C F Smulders; J Renema; A Hulshoff
Journal:  Pharm Weekbl Sci       Date:  1982-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.